Gabelli Funds’s Apollo Endosurgery, Inc. APEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-1,221,882
Closed -$12.1M 1219
2023
Q1
$12.1M Buy
1,221,882
+944,608
+341% +$9.36M 0.09% 279
2022
Q4
$2.76M Buy
+277,274
New +$2.07M 0.02% 591

Gabelli Funds's APEN Position: Q2 2023 in Review

Gabelli Funds sold out of Apollo Endosurgery, Inc. (APEN) in Q2 2023, closing a stake of 1,221,882 shares — an estimated $12.1M sold.

Gabelli Funds first reported a position in APEN in Q4 2022 and held it in 2 quarters. The position peaked at $12.1M in Q1 2023. 0 funds tracked by Wall St. Rank hold APEN as of Q2 2023.

  • Gabelli Funds reported no remaining Apollo Endosurgery, Inc. position as of Q2 2023 after selling out during the quarter.
  • Gabelli Funds sold 1,221,882 Apollo Endosurgery, Inc. shares in Q2 2023, an estimated $12.1M.
  • Gabelli Funds first reported a position in Apollo Endosurgery, Inc. in Q4 2022 and held it in 2 quarters.
  • Gabelli Funds's Apollo Endosurgery, Inc. position peaked at $12.1M in Q1 2023.
  • 0 funds tracked by Wall St. Rank held Apollo Endosurgery, Inc. as of Q2 2023.

Based on Gabelli Funds's 13F filing for Q2 2023, filed 10 Aug 2023.